Search

Barbara E Corkey

from Aventura, FL
Age ~86
Get Report
Also known as:
Barbara Dr Corkey, Barbara Ellen Corkey, Barbara R Corkey
Related to:
Milo B Corkey
Connected to:
Gary Corkhill, 55Linda Corkhill, 73Michael P Corkhill, 47Ernest Corkill, 60Haley Corkill, 34Melanie J Corkill, 67Regina M Corkill, 67Susan M Corkill, 68Anne K Corkin, 56David J Corkin, 85

Barbara Corkey Phones & Addresses

  • Aventura, FL
  • Duxbury, MA
  • 1200 Washington St, Boston, MA 02118 (617) 542-4610 (617) 695-0027 (617) 948-4700
  • 1200 Washington St APT 401, Boston, MA 02118 (617) 908-2957
  • 1180 Washington St, Boston, MA 02118
  • 1180 Washington St #401, Boston, MA 02118
  • 554 Tremont St, Boston, MA 02118
  • Roxbury, MA
  • West Falmouth, MA
  • Los Angeles, CA
  • Walpole, MA

Work

Position: Installation, Maintenance, and Repair Occupations

Education

Degree: Graduate or professional degree

Business Records

Name / Title
Company / Classification
Phones & Addresses
Barbara E. Corkey
President
ADIPOGENIX, INC
Diabetes & Metabolic UNIT 801 ALBANY ST, Boston, MA 02118
554 Tremont St, Boston, MA 02118

Publications

Us Patents

Diagnostic Screens For Type 1 Diabetes (Iddm)

View page
US Patent:
6620583, Sep 16, 2003
Filed:
Jul 9, 2002
Appl. No.:
10/191207
Inventors:
Barbara E. Corkey - Boston MA
Nicholas R. Husni - Boston MA
Assignee:
Boston Medical Center Corporation - Boston MA
International Classification:
C12Q 100
US Classification:
435 4, 453975, 453 29
Abstract:
The present invention features a method for identifying genes or proteins important in insulin-dependent diabetes mellitus (IDDM). The genes or proteins are useful in identifying IDDM-susceptible individuals, and in identifying and testing potential therapeutic agents for the treatment of IDDM.

Novel Diagnostic Screens Type 1 Diabetes (Iddm)

View page
US Patent:
20020018987, Feb 14, 2002
Filed:
Oct 5, 2001
Appl. No.:
09/972305
Inventors:
Barbara Corkey - Boston MA, US
Nicholas Husni - Boston MA, US
Assignee:
Trustees of Boston University
International Classification:
C12Q001/00
G01N033/48
US Classification:
435/004000, 435/040500
Abstract:
The present invention features methods for diagnosing insulin-dependent diabetes mellitus (IDDM) in a test subject, for example a subject at risk of developing IDDM, which involve detecting hyper-responsive Ca mobilization in cells obtained from the test subject. Hyper-responsive Ca mobilization can be detected in cells contacted with a stimulatory agent, preferably in cells contacted with a potentiating agent and a stimulatory agent. Methods of the present invention include comparing Ca mobilization in cells from the test subject to Ca mobilization in cells from a control subject. The present invention further features kits for use in the detection of IDDM.

Methods And Reagents For Identifying Weight Loss Promoters And Therpeutic Uses Therefor

View page
US Patent:
20040161803, Aug 19, 2004
Filed:
Apr 9, 2004
Appl. No.:
10/472984
Inventors:
Barbara Corkey - Boston MA, US
International Classification:
G01N033/53
G01N033/567
C12Q001/26
US Classification:
435/007200, 435/025000
Abstract:
Methods of identifying weight loss promoters are provided. Therapeutic methods utilizing compounds identified according to the methods of the invention are also provided.

Modified-Fat Nutritional Products Useful Preventing Or Treating Obesity

View page
US Patent:
20050019372, Jan 27, 2005
Filed:
Jul 10, 2002
Appl. No.:
10/483350
Inventors:
Barbara Corkey - Boston MA, US
Wen Guo - Stoneham MA, US
Han Jianrong - Stoneham MA, US
International Classification:
A61K047/00
US Classification:
424439000
Abstract:
The present invention provides dietary products for infant child and adult nutrition which possess adequate levels and ratios of medium chain fatty acids and ω-polyunsaturated fatty acids. Consumption of these dietary products can contribute to the prevention of obesity in developing individuals and can contribute to a reduction in body fat mass in individuals who are trying to loose weight or reduce body fat mass (e.g., obese individuals). A first preferred product is a dairy supplement or formulated dairy product for consumption by infants or children to prevent development of obesity. A second preferred product is a dietary suppplement for persons combating unwanted weight gain or obesity. Also featured are methods of formulating these dietary products.

Diagnostic Screens For Type 1 Diabetes (Iddm)

View page
US Patent:
63000555, Oct 9, 2001
Filed:
Aug 20, 1999
Appl. No.:
9/378084
Inventors:
Barbara E. Corkey - Boston MA
Nicholas R. Husni - Boston MA
Assignee:
Trustees of Boston University - Boston MA
International Classification:
C12Q 100
G01N 3353
US Classification:
435 4
Abstract:
The present invention features methods for diagnosing insulin-dependent diabetes mellitus (IDDM) in a test subject, for example a subject at risk of developing IDDM, which involve detecting hyper-responsive Ca. sup. 2+ mobilization in cells obtained from the test subject. Hyper-responsive Ca. sup. 2+ mobilization can be detected in cells contacted with a stimulatory agent, preferably in cells contacted with a potentiating agent and a stimulatory agent. Methods of the present invention include comparing Ca. sup. 2+ mobilization in cells from the test subject to Ca. sup. 2+ mobilization in cells from a control subject. The present invention further features kits for use in the detection of IDDM.
Control profile
Barbara E Corkey from Aventura, FL, age ~86 Get Report